Global Topical drug delivery is one of the most effective ways of drug delivery as it gives optimum therapeutic outcomes.
Global topical drug delivery market is expected to reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at a CAGR of 9.2% in the forecast period 2017 to 2024.
Request Sample Report: Global Topical Drug Delivery Market – Trends and Forecast to 2024
The global topical drug delivery market is segmented on the basis of product type, indication, distribution channel, end user and geography.
MAJOR MARKET DRIVERS:
- RISING CASES OF ACUTE AND CHRONIC DISEASES
- RISING AGING POPULATION
- TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS
- APPROVAL OF NEW DRUGS
- BETTER OPPORTUNITY IN PHARMERGING MARKETS
On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations. Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid.
The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others. In 2017, anti-acne is expected to dominate the market with the highest market share in the forecast period 2017 to 2024.
On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.
Enquiry about the report: Global Topical Drug Delivery Market
Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The countries covered in this report are U.S.
Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.
For More Market and Industry Trends: Global Topical Drug Delivery market is growing at a significant rate in the forecast period 2017-2024
Global Player Operating in the Global Topical Drug Delivery Market:
- Galderma Pharma, S.A.
- Allergen Plc.
- Kaken Pharmaceuticals, Co., Ltd
- Bayer AG
- Hisamitsu Pharmaceuticals, Co., Inc.
- Abbvie, Inc.
- Valeant Pharmaceuticals
- Antares Pharma
- Janssen Pharmaceuticals, Inc. (A J&J Company)
- Crescita Therapeutics
- West Pharmaceutical Services
- Biofarmitalia s.r.l
- Pharmatek Laboratories, Inc.
- Stiefel Laboratories, Inc.
- Acrux Limited
- Nitto Denko Corporation
- Skinvisible Pharmaceuticals, Inc.
- Mylan Pharmaceuticals Inc.
- Pocono Coated Products LLC
- TheraSolve NV.
- Samyang Biopharmaceuticals Corporation
- Lohmann Therapie-Systeme AG
- Prosollus Pharmaceuticals
- Easton Pharmaceuticals Inc.
- Novosis AG
- Endo Pharmaceuticals Inc.
- Transdermal Technologies, Inc.
- Sheffield Pharmaceuticals, Inc.
Category: Market Research Publishers and RetailersCompany profile: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experie ...
For more information: